Urinary Incontinence,Stress
Nephrology·MeSH: Urinary Incontinence, Stress
Prevalence
10000.0 / 100K
Incidence
800.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| Orforglipron | ELI LILLY & Co (LLY) |
Frequently asked questions
How many drugs are in development for Urinary Incontinence,Stress?
BioSniper tracks 1 drug in development for Urinary Incontinence,Stress across 1 company.
How many clinical trials target Urinary Incontinence,Stress?
There are 1 clinical trial targeting Urinary Incontinence,Stress tracked by BioSniper.
What is the prevalence of Urinary Incontinence,Stress?
The estimated prevalence of Urinary Incontinence,Stress is approximately 10000.0 per 100,000 population.
Deep-dive into Urinary Incontinence,Stress
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis